Evidence map›Paper›PMID 25615569›Full record

ArticleAmerican journal of hematology2015

Genome-wide association study follow-up identifies cyclin A2 as a regulator of the transition through cytokinesis during terminal erythropoiesis.

Leif S Ludwig, Hyunjii Cho, Aoi Wakabayashi, Jennifer C Eng, Jacob C Ulirsch, Mark D Fleming, Harvey F Lodish, Vijay G Sankaran

Open access · bronzeAbstract read
In one paragraph

Article in American journal of hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. CDK4/6 inhibitor-induced bone marrow micronuclei might be caused by cell cycle arrest during erythropoiesis.Genes and environment : the official journal of the Japanese Environmental Mutagen Society · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cyclin A2 regulates erythrocyte morphology and numbers.Cell cycle (Georgetown, Tex.) · 2016
    Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Leif S LudwigDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts; Broad Institute of MIT and Harvard, Cambridge, Massachusetts; Whitehead Institute for Biomedical Research, Cambridge, Massachusetts; Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin, Germany; Charité-Universitätsmedizin Berlin, Berlin, Germany.
Hyunjii Cho
Aoi Wakabayashi
Jennifer C Eng
Jacob C Ulirsch
Mark D Fleming
Harvey F Lodish
Vijay G Sankaran
Boston Children's Hospital · USWhitehead Institute for Biomedical Research · USDana-Farber Cancer Institute · USFreie Universität Berlin · DE

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2021
$38.9M
MicroRNAs and hematopoietic differentiationR01DK068348 · NIDDK · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI LODISH, HARVEY F · 2004 to 2019
$8.3M
Systematic Genetic Dissection of Human ErythropoiesisR01DK103794 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Vijay Ganesh Sankaran · 2014 to 2026
$5.9M
Identifying Genome-wide Association Study-Nominated Regulators of ErythropoiesisR21HL120791 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI SANKARAN, VIJAY GANESH · 2014 to 2015
$477k
NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R21 HL120791NIDDK NIH HHS R01 DK068348NIDDK NIH HHS R01 DK103794
6 · The paper itself

Abstract

Genome-wide association studies (GWAS) hold tremendous promise to improve our understanding of human biology. Recent GWAS have revealed over 75 loci associated with erythroid traits, including the 4q27 locus that is associated with red blood cell size (mean corpuscular volume). The close linkage disequilibrium block at this locus harbors the CCNA2 gene that encodes cyclin A2. CCNA2 mRNA is highly expressed in human and murine erythroid progenitor cells and regulated by the essential erythroid transcription factor GATA1. To understand the role of cyclin A2 in erythropoiesis, we have reduced expression of this gene using short hairpin RNAs in a primary murine erythroid culture system. We demonstrate that cyclin A2 levels affect erythroid cell size by regulating the passage through cytokinesis during the final cell division of terminal erythropoiesis. Our study provides new insight into cell cycle regulation during terminal erythropoiesis and more generally illustrates the value of functional GWAS follow-up to gain mechanistic insight into hematopoiesis.

Indexed as

GenomeAnimalsCell DifferentiationCell SizeCyclin A2CytokinesisErythroid Precursor CellsErythropoiesisFollow-Up StudiesGATA1 Transcription FactorGene Expression Regulation, DevelopmentalGenetic LociGenome-Wide Association StudyHumansLinkage DisequilibriumMiceCCNA2 protein, mouseCyclin A2Gata1 protein, mouseGATA1 Transcription FactorRNA, MessengerRNA, Small Interfering

Identifiers

PMID25615569
PMCPMC4409486
OpenAlexW2161465534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.